药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Rolitetracycline
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Sitafloxacin.
Rolitetracycline
Oxatomide
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Oxatomide.
Rolitetracycline
Abexinostat
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Abexinostat.
Rolitetracycline
Mizolastine
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Mizolastine.
Rolitetracycline
Ricolinostat
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Ricolinostat.
Rolitetracycline
Simendan
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Simendan.
Rolitetracycline
CUDC-101
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with CUDC-101.
Rolitetracycline
Entinostat
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Entinostat.
Rolitetracycline
Mocetinostat
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Mocetinostat.
Rolitetracycline
Amifampridine
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Amifampridine.
Rolitetracycline
Dexchlorpheniramine maleate
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Dexchlorpheniramine maleate.
Rolitetracycline
Melperone
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Melperone.
Rolitetracycline
Butriptyline
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Butriptyline.
Rolitetracycline
Eperisone
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Eperisone.
Rolitetracycline
Fendiline
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Fendiline.
Rolitetracycline
Indenolol
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Indenolol.
Rolitetracycline
Bedaquiline
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Bedaquiline.
Rolitetracycline
Antazoline
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Antazoline.
Rolitetracycline
Nemonoxacin
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Nemonoxacin.
Rolitetracycline
Telavancin
The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Telavancin.